Latest filing published 12 Feb 2018 for Inhibitor Therapeutics, Inc..
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Stefan Cross: trading record in brief
Stefan Cross is a declared insider of Inhibitor Therapeutics, Inc., with filings sourced from SEC (Form 4). In total, 3 filings cover trades dated from 8 March 2017 to 19 December 2017.
The open-market record is one-sided, with 1 purchase and not one sale. The totals exclude 1 filing filed without an amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 2 option exercises. Since January 2018: 1 purchase and no sales on the market.
Most recently, on 12 February 2018, the filings show an open-market purchase in Inhibitor Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Stefan Cross
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 600,000 sharesCommon StockSEC:0001144204-18-007442:0Canonical exit: 19 Mar 2018 (T+90)
- 300,000 sharesCommon StockSEC:0000899243-17-007151:0
- 300,000 sharesCommon StockSEC:0000899243-17-007151:1
3 of 3 declarations